ArticleJournal for immunotherapy of cancer2024

Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment.

Anna Tosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.